A federal judge has ruled that three pharmaceutical companies artificially marked up their prices in order to defraud Medicare and encourage doctors to prescribe their drugs over those of competitors.
The decision came in a class-action lawsuit against AstraZeneca, Bristol-Meyers Squibb, Johnson & Johnson and Warwick Pharmaceuticals, a subsidiary of Schering-Plough Corp. U.S. District Judge Patti Saris ruled against AstraZeneca, Bristol-Meyers Squibb and Warwick, while clearing Johnson & Johnson of "egregious misconduct."
The conclusion of this article appears on NaturalNews.com, the independent natural health news source for consumers. This article, along with other related articles and uncensored news on important consumer health topics, can be found at:
U.S. drug companies defrauded Medicare with price fixing scheme, rules judge
NaturalNews is an independent natural health news resource that covers consumer news and how to improve health through foods, herbs, exercise and natural therapies. The site also warns consumers about the dangers of processed foods, pharmaceuticals, chemotherapy, environmental toxins and the failure of government regulators like the FDA.